NAT2 and systemic lupus erythematosus: showed that smokers with the N-acetyltransferase 2 (NAT2) slow acetylator genotype were at a significantly higher risk of SLE (OR 2.34, 95% CI 1.21–4.52) compared with nonsmokers carrying the rapid acetylator genotype (143).